Article Details

Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in US

Retrieved on: 2021-09-02 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Cellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in US. View article details on hiswai:

Excerpt

02, 2021 (GLOBE NEWSWIRE) -- Reflecting continued clinical progress, Cellect Biotechnology Ltd. (NASDAQ: “APOP”), announced the first ApoGraftTM ...

Article found on: www.bakersfield.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up